SIGALA, SANDRA
 Distribuzione geografica
Continente #
NA - Nord America 11.265
AS - Asia 5.717
EU - Europa 4.914
SA - Sud America 933
AF - Africa 123
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 5
Totale 22.975
Nazione #
US - Stati Uniti d'America 11.094
SG - Singapore 1.994
CN - Cina 1.910
UA - Ucraina 897
IT - Italia 852
BR - Brasile 759
HK - Hong Kong 647
DE - Germania 621
PL - Polonia 582
FR - Francia 476
FI - Finlandia 464
VN - Vietnam 406
GB - Regno Unito 275
RU - Federazione Russa 213
TR - Turchia 186
IN - India 185
IE - Irlanda 163
CA - Canada 97
SE - Svezia 93
BD - Bangladesh 84
JP - Giappone 60
BE - Belgio 57
NL - Olanda 57
AR - Argentina 56
ID - Indonesia 49
IQ - Iraq 43
ZA - Sudafrica 39
MX - Messico 37
CZ - Repubblica Ceca 34
EC - Ecuador 31
ES - Italia 28
PK - Pakistan 27
VE - Venezuela 20
CL - Cile 19
AT - Austria 18
CO - Colombia 17
NG - Nigeria 16
AU - Australia 15
MA - Marocco 14
UZ - Uzbekistan 13
LT - Lituania 12
EG - Egitto 11
IR - Iran 11
KE - Kenya 11
PY - Paraguay 11
SA - Arabia Saudita 11
DK - Danimarca 10
EE - Estonia 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
CR - Costa Rica 8
BG - Bulgaria 7
DZ - Algeria 7
JM - Giamaica 7
PE - Perù 7
PH - Filippine 7
AZ - Azerbaigian 6
JO - Giordania 6
KR - Corea 6
MU - Mauritius 6
BO - Bolivia 5
IL - Israele 5
LB - Libano 5
MY - Malesia 5
NP - Nepal 5
OM - Oman 5
PS - Palestinian Territory 5
PT - Portogallo 5
UY - Uruguay 5
AL - Albania 4
EU - Europa 4
GR - Grecia 4
HN - Honduras 4
KG - Kirghizistan 4
KZ - Kazakistan 4
RO - Romania 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
TW - Taiwan 4
BB - Barbados 3
BH - Bahrain 3
GY - Guiana 3
HU - Ungheria 3
LV - Lettonia 3
NI - Nicaragua 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
CY - Cipro 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GD - Grenada 2
GE - Georgia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PA - Panama 2
SY - Repubblica araba siriana 2
Totale 22.959
Città #
Fairfield 1.045
Singapore 1.006
Ashburn 981
Woodbridge 835
Jacksonville 652
Hong Kong 642
Warsaw 577
Houston 531
San Jose 512
Seattle 426
Cambridge 421
Dallas 381
Ann Arbor 376
Beijing 359
Wilmington 356
Chandler 339
Princeton 291
The Dalles 289
Helsinki 278
Los Angeles 273
New York 254
Chicago 251
Nanjing 227
Brescia 213
Dearborn 169
Dublin 163
Lauterbourg 156
Istanbul 149
Ho Chi Minh City 123
Munich 109
Des Moines 108
Nanchang 108
Salt Lake City 100
Buffalo 97
Council Bluffs 87
Moscow 86
Hanoi 76
Milan 70
Shenyang 70
Secaucus 67
Shanghai 65
São Paulo 65
Turku 64
Santa Clara 63
Changsha 60
Jinan 57
Brussels 56
Redondo Beach 55
San Diego 55
Tianjin 54
Orem 53
Elk Grove Village 52
Tampa 52
San Francisco 49
Dong Ket 48
Hebei 48
Pune 45
West Jordan 44
Lancaster 41
London 41
Toronto 41
Tokyo 38
Boardman 33
Rome 33
Kunming 32
Jakarta 31
Jiaxing 31
Sterling 31
Brooklyn 30
Ningbo 28
Phoenix 25
Rio de Janeiro 25
Chennai 24
Brno 23
Verona 23
Zhengzhou 23
Hangzhou 22
Johannesburg 22
Montreal 22
Frankfurt am Main 21
Guangzhou 21
Taizhou 21
Amsterdam 20
Haiphong 20
Nuremberg 20
Stockholm 20
Atlanta 18
Boston 18
Dalmine 18
Haikou 17
Poplar 17
Denver 16
Kyiv 16
Manchester 16
Miami 16
Abuja 15
Da Nang 15
Düsseldorf 15
Naples 15
Norwalk 15
Totale 15.227
Nome #
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 790
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 380
1,25(OH)2 vitamin D(3) contributes to osteoclast-like trans-differentiation of malignant plasma cells 377
Adrenocortical carcinoma xenograft in zebrafish embryos as model to study the in vivo cytotoxicity of abiraterone acetate 311
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 296
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice. 278
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 255
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 249
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 246
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 226
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 225
Immunotherapy failure in adrenocortical cancer: where next? 223
[Acetylcholine induces human detrusor muscle cell proliferation: molecular and pharmacological characterization.] 212
Neoadjuvant treatment approach: The rosetta stone for breast cancer? 211
Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy 210
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 207
Management of Severe Cushing Syndrome Induced by Adrenocortical Carcinoma with Abiraterone Acetate: A Case Report 207
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 207
I recettori muscarinici stimolano la proliferazione di leiomiociti derivati da muscolo detrusore umano 205
An Integrated Approach for a Structural and Functional Evaluation of Biosimilars: Implications for Erythropoietin 205
Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents 205
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 200
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 199
Should Adjuvant Weekly Paclitaxel Be Considered Less Efficacious Than Anthracyclines Plus Cyclophosphamide for Lower Risk Patients With Early-Stage Breast Cancer? 197
Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines 194
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity 191
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma 190
Palbociclib inhibits proliferation of human adrenocortical tumor cells 189
Localization of TNF alpha in ileocolonic biopsies of patients with inflammatory bowel disease 188
Inhibition of Survivin Is Associated with Zoledronic Acid-induced Apoptosis of Prostate Cancer Cells 185
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 182
MUSCARINIC RECEPTORS STIMULATE CELL PROLIFERATION IN THE HUMAN UROTHELIUM-DERIVED CELL LINE UROtsa 181
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 180
Different muscarinic receptor subtypes modulate proliferation of primary human detrusor smooth muscle cells via Akt/PI3K and map kinases. 180
A new pharmacological approach to the facilitation of acetylcholine transmission. 178
Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials 173
A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers 169
Alpha1 adrenoceptor subtypes in human urinary bladder: sex and regional comparison. 164
Activation of NF-kappaB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP(+) toxicity in SK-N-SH cells. 164
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 164
Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials 163
Cisplatin Cytotoxicity in Human Testicular Germ Cell Tumor Cell Lines Is Enhanced by the CDK4/6 Inhibitor Palbociclib 159
INVOLVEMENT OF TARGET GENE POLYMORPHISMS IN 5-FLUOROURACIL TOXICITY: A CASE REPORT 159
Computational and functional analysis of biopharmaceutical drugs in zebrafish: Erythropoietin as a test model 157
Should we be cautious on the use of commercially available antibodies to dopamine receptors? 157
Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall? 156
Molecular target agents in adrenocortical carcinoma: rationale and difficulties in trial design 155
Opposing roles for D-1 and D-2 dopamine receptors in the regulation of lower esophageal sphincter motility in the rat. 154
Nerve growth factor in the anterior pituitary: localization in mammotroph cells and co-secretion with prolactin by a dopamine-regulated mechanism 153
A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma 152
The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines 148
Parallelism of Chemicostructural Properties between Filgrastim Originator and Three of Its Biosimilar Drugs 147
Nerve growth factor directs differentiation of the bipotential cell line GH-3 into the mammotroph phenotype 146
Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment. 145
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 145
Lack of coupling of D2 receptors to adenylate cyclase in GH3 cells exposed to epidermal growth factor. Possible role of a differential expression of Gi protein subtypes 142
Nerve growth factor and retinoic acid interactions in the control of small cell lung cancer proliferation. 140
The role of the prostatic stroma in chronic prostatitis/chronic pelvic pain syndrome. 137
Current evidence and future perspectives about the role of iXip® in the diagnosis of prostate cancer 137
Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. 136
Different neurotransmitter systems are involved in the development of esophageal achalasia 135
Differential gene expression of cholinergic muscarinic receptor subtypes in male and female normal human urinary bladder. 135
Adrenocortical carcinoma 134
Dopamine receptors are present in rat and human esophagus 133
Nerve growth factor signaling in prostate health and disease. 133
Angiotensin II differentially affects cyclic AMP formation in intact adrenal glomerulosa cells and in purified membrane preparations 131
Sex-related variations in serum nerve growth factor concentration in humans. 131
Evidence for the presence of both D-1 and D-2 dopamine receptors in human esophagus. 130
Detection of muscarinic receptor subtypes in human urinary bladder mucosa: Age and gender-dependent modifications 130
Erratum to "Muscarinic receptors stimulate cell proliferation in the human urothelium-derived cell line UROtsa" [Pharmacol. Res. 64 (2011) 420-425] 129
Nerve growth factor suppresses the tumoral phenotype of human prolactinomas 128
Clinical Outcome After Extended Endovascular Recanalization in Buerger's Disease in 20 Consecutive Cases. 128
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. 128
Increased serum concentration of nerve growth factor in patients with microprolactinoma. 126
Gene expression profile of prostate cancer cell lines: Effect of nerve growth factor treatment 126
Docetaxel plus androgen deprivation withdrawal may restore sensitivity to luteinizing hormone-releasing hormone analog therapy in castration-resistant prostate cancer patients 126
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 125
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 125
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 124
Selective disarrangement of the rostral telencephalic cholinergic system in heterozygous reeler mice. 123
Caffeine inhibits Direct and Indirect Angiogenesis in zebrafish embryos 122
Inhibition of aldosterone secretion by dopamine, ibopamine, and dihydroergotoxine in patients with congestive heart failure 122
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 122
I RECETTORI ADRENERGICI ALFA-1 NELL'APPARATO URINARIO UMANO: ESPRESSIONE DISTRIBUZIONE E LORO IMPLICAZIONI CLINICHE 120
Evidence for the presence of D1 and D2 dopamine receptors in rat oesophagus 119
Nerve growth factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism 119
Gene expression profile of prostate cancer cell lines: effect of nerve growth factor treatment 117
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 116
Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines 116
Structural comparison Analysis of Erythropoietin and its biosimilars by a proteomic approach 116
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 116
Ruolo dei recettori della dopamina nella regolazione motoria dello sfintere esofageo inferiore del ratto 115
ALPHA 1 ADRENERGIC RECEPTOR SUBTYPES IN MALE AND FEMALE HUMAN URINARY BLADDER: SEX AND REGIONAL COMPARISON 115
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 112
The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study 111
Differential gene expression of dopamine D-2 receptor subtypes in rat chromaffin cells and sympathetic neurons in culture. 111
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 110
D-1 and D-2 dopamine receptors in rat lower esophageal sphincter: a functional study 110
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 109
Molecular and pharmacological detection of dopaminergic receptors in the human male urinary tract 109
Totale 17.068
Categoria #
all - tutte 100.712
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.712


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021341 0 0 0 0 0 0 0 0 0 0 224 117
2021/20221.260 120 185 38 68 15 58 63 76 61 154 112 310
2022/20231.075 190 62 48 81 83 260 6 90 134 14 39 68
2023/20241.412 72 39 126 101 82 256 49 67 284 73 34 229
2024/20254.152 56 47 32 529 341 246 295 109 491 248 942 816
2025/20266.670 550 864 757 917 608 391 978 312 436 668 189 0
Totale 23.316